Adjuvant and extended adjuvant use of aromatase inhibitors: Reducing the risk of recurrence and distant metastasis
Adjuvant and extended adjuvant use of aromatase inhibitors: Reducing the risk of recurrence and distant metastasis. The Breast Supplement: St. Gallen (sponsored by Novartis Oncology). 2007; pending publication.